老虎證券

美股詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務

BriaCell Therapeutics Corp.

3.56
-0.0700-1.93%
盤後：3.560.00000.00%19:37 EDT
成交量：9.62萬
成交額：34.73萬
市值：3,097.13萬
市盈率：-0.37
高：3.65
開：3.58
低：3.56
收：3.63
52周最高：14.68
52周最低：2.60
股本：869.98萬
流通股本：785.96萬
量比：0.97
換手率：1.22%
股息：- -
股息率：- -
每股收益(TTM):-9.6592
每股收益(LYR):-62.1862
淨資產收益率：-175.25%
總資產收益率：-90.84%
市淨率：1.29
市盈率(LYR):-0.06

資料載入中...

總覽公司新聞資訊公告
2021/03/02

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/26

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/26

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/18

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2021/02/18

SEC問詢函

CORRESP [Cover] - Correspondence
2021/02/18

SEC問詢函

CORRESP [Cover] - Correspondence
2021/02/18

SEC問詢函

CORRESP [Cover] - Correspondence
2021/02/03

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2021/02/02

SEC問詢函

CORRESP [Cover] - Correspondence
2021/01/15

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2021/01/14

SEC問詢函

CORRESP [Cover] - Correspondence
2020/12/23

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/12/22

SEC問詢函

CORRESP [Cover] - Correspondence
2020/12/10

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/12/10

SEC問詢函

CORRESP [Cover] - Correspondence
2020/10/20

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/10/20

SEC問詢函

CORRESP [Cover] - Correspondence
2020/09/18

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/05/27

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/05/27

SEC問詢函

CORRESP [Cover] - Correspondence
更多